Tumor angiogenesis in predicting the survival of patients with stage i lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 5, 2010, Pages 996-1000

  Medetoglu, Baris ^a   Gunluoglu, Mehmet Zeki ^a   Demir, Adalet ^a   Melek, Huseyin ^a   Buyukpinarbasili, Nur ^a   Fener, Neslihan ^a   Dincer, Seyyit Ibrahim ^a  

^a Yedikule Teaching Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; VASCULOTROPIN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; MICROVASCULATURE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; CARCINOMA, NON-SMALL-CELL LUNG; CHEMISTRY; CHI SQUARE DISTRIBUTION; KAPLAN MEIER METHOD; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TIME; TREATMENT OUTCOME; TURKEY; VASCULARIZATION;

ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; TURKEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; KAPLAN-MEIER ESTIMATE;

EID: 77958022915     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.07.002     Document Type: Article

References (19)

1. C.F. Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
2. P.C. Pairolero, D.E. Williams, E.J. Bergstralh, J.M. Piehler, P.E. Bernatz, and W.S. Payne Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease Ann Thorac Surg 38 1984 331 338
3. G. Buccheri, and D. Ferrigno Prognostic factors in lung cancer: tables and comments Eur Respir J 7 1994 1350 1364 (Pubitemid 24235056)
4. S. Kumar, A. Ghellal, C. Li, G. Byrne, N. Haboubi, and J.M. Wang Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis Cancer Res 59 1999 856 861
5. F. Tanaka, S. Ishikawa, K. Yanagihara, R. Miyahara, Y. Kawano, and M. Li Expression of angiopoietins and its clinical significance in non-small cell lung cancer Cancer Res 62 2002 7124 7129 (Pubitemid 35424109)
6. W.D. Travis, T.V. Colby, B. Corrin, Y. Shimosato, and E. Brambilla Histological typing of tumours of lung and pleura L.H. Sobin, World Health Organization international classification of tumours 3rd ed. 1999 Springer-Verlag Berlin
7. L.T. Tanoue, and R.A. Matthay Lung cancer: epidemiology and carcinogenesis T.W. Shields, General thoracic surgery 5th ed. 2000 Lippincott Williams & Wilkins Philadelphia 1215 1228
8. R. Baillie, J. Carlile, N. Pendleton, and A.M. Schor Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer J Clin Pathol 54 2001 116 120
9. G. Fontanini, S. Vignati, L. Boldrini, S. Chin, V. Silvestri, and M. Lucchi Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma Clin Cancer Res 3 1997 861 865
10. L.Y. Yang, W.Q. Lu, G.W. Huang, and W. Wang Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma BMC Cancer 6 2006 110
11. P. Macchiarini, G. Fontanini, E. Dulmet, V. de Montpreville, A.R. Chapelier, and J. Cerrina Angiogenesis: an indicator of metastasis in non-small cell lung cancer invading the thoracic inlet Ann Thorac Surg 57 1994 1534 1539
12. R.M. Bremnes, C. Camps, and R. Sirera Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood Lung Cancer 51 2006 143 158
13. M.I. Koukourakis, A. Giatromanolaki, P.E. Thorpe, R.A. Brekken, E. Sivridis, and S. Kakolyris Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer Cancer Res 60 2000 3088 3095
14. R.S. Saad, Y.L. Liu, G. Nathan, J. Celebrezze, D. Medich, and J.F. Silverman Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer Mod Pathol 17 2004 197 203
15. A. Yuan, C.J. Yu, C.T. Shun, K.T. Luh, S.H. Kuo, and Y.C. Lee Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients Int J Cancer 115 2005 545 555
16. K.J. O'Byrne, M.I. Koukourakis, A. Giatromanolaki, G. Cox, H. Turley, and W.P. Steward Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer Br J Cancer 82 2000 1427 1432 (Pubitemid 30175909)
17. T.C. Mineo, V. Ambrogi, A. Baldi, C. Rabitti, P. Bollero, and B. Vincenzi Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer J Clin Pathol 57 2004 591 597
18. M. Decaussin, H. Sartelet, C. Robert, D. Moro, C. Claraz, and C. Brambilla Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival J Pathol 188 1999 369 377
19. M. Takahama, M. Tsutsumi, T. Tsujiuchi, A. Kido, E. Okajima, and K. Nezu Frequent expression of the vascular endothelial growth factor in human non-small-cell lung cancers Jpn J Clin Oncol 28 1998 176 181